VR22 Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP8936c
Other Names:
Catenin alpha-3, Alpha T-catenin, Cadherin-associated protein, CTNNA3 {ECO:0000312|EMBL:AAF218011, ECO:0000312|HGNC:HGNC:2511}
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8936c was selected from the Center region of human VR22. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CTNNA3 {ECO:0000312|EMBL:AAF21801.1, ECO:0000312|HGNC:HGNC:2511}
Gene ID: 29119
Primary Accession: Q9UI47
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Catenin alpha-3, Alpha T-catenin, Cadherin-associated protein, CTNNA3 {ECO:0000312|EMBL:AAF218011, ECO:0000312|HGNC:HGNC:2511}
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8936c was selected from the Center region of human VR22. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CTNNA3 {ECO:0000312|EMBL:AAF21801.1, ECO:0000312|HGNC:HGNC:2511}
Gene ID: 29119
Primary Accession: Q9UI47
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review